연구동향 분석

Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study

이재욱 유재원 김성구 장필상 정낙균 조빈 2022년

논문상세정보
인용/피인용
' Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Children
  • Extramedullary involvement
  • Hematopoietic stem cell transplantation
  • Relapse
  • acute myeloid leukemia
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
819 0

0.0%

' Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study' 의 참고문헌

  • Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia : a phase 1, dose-escalation study
    Karol SE [2020]
  • Treatment of children with acute myeloid leukaemia who relapsed after allogeneic haematopoietic stem cell transplantation
    Lee JW [2013]
  • The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia : results of the international study Relapsed AML 2001/01
    Creutzig U [2014]
  • The outcomes of relapsed acute myeloid leukemia in children : results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study
    Moritake H [2021]
  • Survival following relapse in children with acute myeloid leukemia : a report from AML-BFM and COG
    Rasche M [2021]
  • Successes and challenges in the treatment of pediatric acute myeloid leukemia : a retrospective analysis of the AML-BFM trials from 1987 to 2012
    Rasche M [2018]
  • Prognostic role of postinduction minimal residual disease and myeloid sarcoma type extramedullary involvement in pediatric RUNX1-RUNX1T1(+)acute myeloid leukemia
    Lee JW [2020]
  • Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98
  • Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia
    Rubnitz JE [2007]
  • Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia
    Ravandi F [2010]
  • Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol
    Nakayama H [2014]
  • Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia : a retrospective I-BFM analysis of 333 children
    Uden T [2020]
  • Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party
    Webb DK [1999]
  • Outcome for children treated for relapsed or refractory acute myelogenous leukemia(rAML) : a Therapeutic Advances in Childhood Leukemia(TACL)Consortium study
    Gorman MF [2010]
  • Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia
    Karlsson L [2017]
  • Improved outcome in pediatric relapsed acute myeloid leukemia : results of a randomized trial on liposomal daunorubicin by the International BFM Study Group
    Kaspers GJ [2013]
  • IDA-FLAG(idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation : experiences of a phase II trial
  • Hematopoietic stem cell transplantation for children with acute myeloid leukemia in second remission : a report from the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children’s Haematology Oncology Group
    Selim A [2019]
  • Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia : a report by Berlin-Frankfurt-Munster study group
    Niktoreh N [2019]
  • Extramedullary leukemia in children with acute myeloid leukemia : a population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology(NOPHO)
    Stove HK [2017]
  • Effect of extramedullary disease on alloge-neic hematopoietic cell transplantation for pediatric acute myeloid leukemia : a nationwide retrospective study
    Sakaguchi H [2021]
  • Consequent and intensified relapse therapy improved survival in pediatric AML : results of relapse treatment in 379 patients of three consecutive AML-BFM trials
    Sander A [2010]
  • A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia
    Yahng SA [2015]